Algerian firm Pharma Invest has entered into a partnership with China's Yangtze River Pharmaceutical Group (YRPG) to boost the domestic production of innovative medicines and pharmaceutical raw materials. Signed in Algiers in the presence of the Minister of Pharmaceutical Industry and the CEO of the Saidal group, the agreement focuses on the transfer of advanced technologies to improve local industrial capabilities. This initiative aims to bolster national health sovereignty by enhancing production quality. Additionally, steps were taken toward a future collaboration between Pharma Invest and Saidal, focused on the manufacturing and distribution of high-value pharmaceutical products.